drugset / Trial / NCT00558064
Filtered Trial for Amlodipine Non-responder
Parallel-groupTreatment
Summary
To demonstrate that a fixed-dose combination of telmisartan 40 mg plus amlodipine 5 mg is superior to amlodipine 5 mg alone in patients with essential hypertension and inadequately controlled with amlodipine 5 mg monotherapy.
Timeline
- Start
- 2007-10
- Primary completion
- 2008-09
- Completion
- —
Outcome
Met primary endpoint
registry Telmisartan 40 mg Plus Amlodipine 5 mg Fixed-dose Combination vs Amlodipine 5 mg Monotherapy; p <0.0001; Mean Difference (Final Values) 5.11 (95% CI 3.98 to 6.23) NCT00558064 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | — |
| Subject | Telmisartan | Other / unclassified | 40 mg | — |